157 related articles for article (PubMed ID: 26531287)
1. Property and current clinical applications of mammal hyaluronidase.
Lv SH; Rong SF; Cai BG; Guan SM; Li QQ
Eur Rev Med Pharmacol Sci; 2015 Oct; 19(20):3968-76. PubMed ID: 26531287
[TBL] [Abstract][Full Text] [Related]
2. Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look.
Whatcott CJ; Han H; Posner RG; Hostetter G; Von Hoff DD
Cancer Discov; 2011 Sep; 1(4):291-6. PubMed ID: 22053288
[TBL] [Abstract][Full Text] [Related]
3. Dose- and time-dependent effects of hyaluronidase on structural cells and the extracellular matrix of the skin.
Buhren BA; Schrumpf H; Gorges K; Reiners O; Bölke E; Fischer JW; Homey B; Gerber PA
Eur J Med Res; 2020 Nov; 25(1):60. PubMed ID: 33228813
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronidases in Human Diseases.
Kaul A; Short WD; Wang X; Keswani SG
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809827
[TBL] [Abstract][Full Text] [Related]
5. Purification of hyaluronidase as an anticancer agent inhibiting CD44.
Shakouri A; Parvan R; Adljouy N; Abdolalizadeh J
Biomed Chromatogr; 2020 Jan; 34(1):e4709. PubMed ID: 31630417
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronan Depolymerization by Megakaryocyte Hyaluronidase-2 Is Required for Thrombopoiesis.
Petrey AC; Obery DR; Kessler SP; Flamion B; de la Motte CA
Am J Pathol; 2016 Sep; 186(9):2390-403. PubMed ID: 27398974
[TBL] [Abstract][Full Text] [Related]
7. Ultraviolet-B irradiation induces differential regulations of hyaluronidase expression and activity in normal human keratinocytes.
Kurdykowski S; Mine S; Bardey V; Danoux L; Jeanmaire C; Pauly G; Brabencova E; Wegrowski Y; Maquart FX
Photochem Photobiol; 2011; 87(5):1105-12. PubMed ID: 21699545
[TBL] [Abstract][Full Text] [Related]
8. The six hyaluronidase-like genes in the human and mouse genomes.
Csoka AB; Frost GI; Stern R
Matrix Biol; 2001 Dec; 20(8):499-508. PubMed ID: 11731267
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronidases--a group of neglected enzymes.
Kreil G
Protein Sci; 1995 Sep; 4(9):1666-9. PubMed ID: 8528065
[TBL] [Abstract][Full Text] [Related]
10. Can Plasma Hyaluronan and Hyaluronidase Be Used As Markers of the Endothelial Glycocalyx State in Patients with Kidney Disease?
Vlahu CA; Krediet RT
Adv Perit Dial; 2015; 31():3-6. PubMed ID: 26714379
[TBL] [Abstract][Full Text] [Related]
11. Standardized in vitro analysis of the degradability of hyaluronic acid fillers by hyaluronidase.
Buhren BA; Schrumpf H; Bölke E; Kammers K; Gerber PA
Eur J Med Res; 2018 Aug; 23(1):37. PubMed ID: 30122153
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronan degrading silica nanoparticles for skin cancer therapy.
Scodeller P; Catalano PN; Salguero N; Duran H; Wolosiuk A; Soler-Illia GJ
Nanoscale; 2013 Oct; 5(20):9690-8. PubMed ID: 23969526
[TBL] [Abstract][Full Text] [Related]
13. Insights into the source, mechanism and biotechnological applications of hyaluronidases.
Zhang YS; Gong JS; Yao ZY; Jiang JY; Su C; Li H; Kang CL; Liu L; Xu ZH; Shi JS
Biotechnol Adv; 2022 Nov; 60():108018. PubMed ID: 35853550
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer.
Ekici S; Cerwinka WH; Duncan R; Gomez P; Civantos F; Soloway MS; Lokeshwar VB
Int J Cancer; 2004 Oct; 112(1):121-9. PubMed ID: 15305383
[TBL] [Abstract][Full Text] [Related]
15. Fragmented hyaluronan is an autocrine chemokinetic motility factor supported by the HAS2-HYAL2/CD44 system on the plasma membrane.
Saito T; Kawana H; Azuma K; Toyoda A; Fujita H; Kitagawa M; Harigaya K
Int J Oncol; 2011 Nov; 39(5):1311-20. PubMed ID: 21743962
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of a bacterial hyaluronidase and its production in recombinant form.
Messina L; Gavira JA; Pernagallo S; Unciti-Broceta JD; Sanchez Martin RM; Diaz-Mochon JJ; Vaccaro S; Conejero-Muriel M; Pineda-Molina E; Caruso S; Musumeci L; Di Pasquale R; Pontillo A; Sincinelli F; Pavan M; Secchieri C
FEBS Lett; 2016 Jul; 590(14):2180-9. PubMed ID: 27311405
[TBL] [Abstract][Full Text] [Related]
17. Structures of vertebrate hyaluronidases and their unique enzymatic mechanism of hydrolysis.
Jedrzejas MJ; Stern R
Proteins; 2005 Nov; 61(2):227-38. PubMed ID: 16104017
[TBL] [Abstract][Full Text] [Related]
18. Devising a pathway for hyaluronan catabolism: are we there yet?
Stern R
Glycobiology; 2003 Dec; 13(12):105R-115R. PubMed ID: 14514708
[TBL] [Abstract][Full Text] [Related]
19. Aberrant serum hyaluronan and hyaluronidase levels in scleroderma.
Neudecker BA; Stern R; Connolly MK
Br J Dermatol; 2004 Mar; 150(3):469-76. PubMed ID: 15030329
[TBL] [Abstract][Full Text] [Related]
20. Clinical Applications of Hyaluronidase.
Weber GC; Buhren BA; Schrumpf H; Wohlrab J; Gerber PA
Adv Exp Med Biol; 2019; 1148():255-277. PubMed ID: 31482503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
